Snup acute 0.1% nasal spray 15 ml

To reduce swelling of the nasal mucosa in the case of a cold, in the case of a runny nose that occurs in attacks (vasomotor rhinitis) and in the case of allergic rhinitis (allergic rhinitis). To facilitate the drainage of secretions in the case of catarrh in the nose and middle ear area in connection with a cold.
If you do not feel better after 7 days or if you feel worse, contact your doctor.

Contraindications

Snup® acute 0.1% must not be used

• if you are allergic to xylometazoline or one of the other ingredients of Snup® acute 0.1% mentioned in section 6.
• if your pituitary gland (pituitary gland) has been removed via the sphenoid bone.
• if you have inflammation of the skin and mucous membrane of the nasal cavity and crusting (rhinitis sicca).
• if you have narrow-angle glaucoma.
• after certain surgical procedures.

Interactions

When Snup® acute and certain mood-enhancing medications (monoamine oxidase inhibitors, tricyclic or tetracyclic antidepressants) are used at the same time, interactions can lead to an increase in blood pressure.

Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Snup® acute 0.1% may only be used during pregnancy and breastfeeding after consulting your doctor.

Pregnancy
Xylometazoline may only be used during pregnancy after careful benefit/risk assessment. Since an overdose can affect the blood supply to the unborn child, the recommended dose must not be exceeded during pregnancy.

Breast-feeding
It is not known whether xylometazoline passes into breast milk. Xylometazoline may only be used during breastfeeding after careful benefit/risk assessment. Since an overdose can inhibit milk production, the recommended dose must not be exceeded while breastfeeding.

Application

The recommended dose is:
Adults, adolescents and children over 10 years:
1 spray (0.09 ml) in each nostril, no more than 3 times a day and a maximum of 7 days in a row.
After using the medicine, you must wait at least 8 hours before taking the next dose.

Snup® acute 0.05% nasal spray is available for children under the age of 10.

Depending on the extent and nature of the symptoms (one or both sides of the nose blocked), the medicine can initially be applied only to the more blocked nostril until the symptoms on that side have improved.

For nasal use.

Side effects

Possible side effects:

Heart diseases
Rare: palpitations, rapid heartbeat, systemic effects, especially after overdose. Very rare: cardiac arrhythmias

Nervous system disorders:
Rare: nervousness, sleep disorders, temporary and mild visual disturbances
Very rare: headache, cramps (especially in children), insomnia, tiredness

Respiratory, thoracic and mediastinal disorders:
Common: burning or dryness of the nasal mucosa, sneezing
Uncommon: increased swelling of the mucous membranes after the effect has worn off (reactive hyperemia), nosebleeds
Very rare: respiratory arrest (reported for use in small children and newborns)

Prolonged or too frequent use as well as higher doses can lead to burning or dryness of the nasal mucosa, which can occur after more than 5 to 7 days of treatment. The result can be permanent damage to the mucous membrane with the clinical picture “dry nose” (rhinitis sicca).

Vascular diseases
Rare: high blood pressure

General disorders and administration site conditions
Very rare: Fatigue (drowsiness, sedation)

Immune system disorders
Uncommon: hypersensitivity reactions (sudden swelling (angioedema), rash, itching)

Psychiatric disorders
Very rare: restlessness, sleep disorders, hallucinations (especially in children)

composition

What Snup® akut 0.1% contains

• The active ingredient is: xylometazoline hydrochloride
  1 ml solution contains 1 mg xylometazoline hydrochloride.
  1 spray (approx. 0.09 ml solution) contains 0.09 mg xylometazoline hydrochloride.
• The other ingredients are:
  sea water, potassium dihydrogen phosphate, purified water.